Francis A. Farraye, MD

Adjunct Professor, Medicine

Francis Farraye
85 E. Concord St


Dr. Farraye is a Senior Associate Consultant in the Section of Gastroenterology and Hepatology at the Mayo Clinic in Jacksonville Florida where he co-directs the Inflammatory Bowel Disease Center. Prior to relocating in 2019, he was Clinical Director in the Section of Gastroenterology and the Inflammatory Bowel Disease Center at Boston Medical Center. At Boston University School of Medicine, he was Professor of Medicine. Dr. Farraye earned his medical doctorate from the Albert Einstein College of Medicine in New York and his master’s degree in Epidemiology from the Harvard School of Public Health.

Dr. Farraye’s clinical interests are in the care of patients with inflammatory bowel disease. He is currently investigating C. difficile infection in IBD patients, the management and diagnosis of dysplasia and cancer in patients with IBD; social media use and health literacy in IBD patients; hepatitis B vaccination efficacy in patients with IBD; and subclinical hepatic fibrosis in patients with IBD.

A frequent speaker and invited lecturer on topics on the diagnosis and management of inflammatory bowel disease, Dr. Farraye has authored or co-authored over 450 original scientific manuscripts, book chapters, reviews, and abstracts. He is the series editor for the text Curbside Consultations in Gastroenterology and co-edited the text, Curbside Consultation in Inflammatory Bowel Disease and Gastrointestinal Emergencies. His books for patients include Questions and Answers about Ulcerative Colitis, Questions and Answers about Crohn’s Disease and Ulcerative Colitis for Dummies.

Dr. Farraye is a Fellow of the American Society of Gastrointestinal Endoscopy, American Gastroenterological Association and the American College of Gastroenterology. He has served on numerous national and international committees including as a member of the ACG Board of Trustees. He is co-chair of the Crohn’s and Colitis Foundation Membership Committee and a member of the Chapter Medical Advisory Committee for the New England Crohn’s and Colitis Foundation and a past chairman. The New England Crohn’s and Colitis Foundation named Dr. Farraye Humanitarian of the Year in 2003. In 2009, the ACG awarded Dr. Farraye the William Carey Award for service to the college. Dr. Farraye has been recognized as “Top Doctor” in Gastroenterology by Boston Magazine and U.S. News and World Report since 2010.

Other Positions

  • Member, Center for Regenerative Medicine, Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University


  • Albert Einstein College of Medicine, MD
  • Harvard School of Public Health, MSc
  • Stony Brook University, BS


  • Published on 3/30/2022

    Patil SA, Bhat S, Limdi JK, Farraye FA, Cross RK. The Sincerest Form of Flattery? Biosimilars in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2022 Mar 30. PMID: 35353189.

    Read at: PubMed
  • Published on 3/1/2022

    Kappelman MD, Weaver KN, Zhang X, Dai X, Watkins R, Adler J, Dubinsky MC, Kastl A, Bousvaros A, Strople JA, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda EA, Farraye FA, Boccieri ME, Firestine A, Chun KY, Fernando M, Bastidas M, Zikry M, Long MD. Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases. Am J Gastroenterol. 2022 03 01; 117(3):462-469. PMID: 35029167.

    Read at: PubMed
  • Published on 2/15/2022

    Limdi JK, Farraye FA. Real-time use of artificial intelligence at colonoscopy predicts relapse in ulcerative colitis: predicting with "intelligence". Gastrointest Endosc. 2022 04; 95(4):757-759. PMID: 35177257.

    Read at: PubMed
  • Published on 2/14/2022

    Kröner PT, Picco MF, Cangemi JR, Hayney MS, Farraye FA, Caldera F. The Burden of Vaccine-preventable Diseases in Patients With Inflammatory Bowel Disease. J Clin Gastroenterol. 2022 Feb 14. PMID: 35152238.

    Read at: PubMed
  • Published on 2/7/2022

    Kwon J, Fluxá D, Farraye FA, Kröner PT. Cytomegalovirus-related colitis in patients with inflammatory bowel disease. Int J Colorectal Dis. 2022 Mar; 37(3):685-691. PMID: 35132443.

    Read at: PubMed
  • Published on 2/1/2022

    Click B, Merchea A, Colibaseanu DT, Regueiro M, Farraye FA, Stocchi L. Ileocolic Resection for Crohn Disease: The Influence of Different Surgical Techniques on Perioperative Outcomes, Recurrence Rates, and Endoscopic Surveillance. Inflamm Bowel Dis. 2022 02 01; 28(2):289-298. PMID: 33988234.

    Read at: PubMed
  • Published on 1/19/2022

    Caldera F, Wald A, Saha S, Smith R, McCrone S, Farraye FA, Hayney MS. Equivalent Cellular and Humoral Immunity to Varicella Zoster Virus in Patients With Inflammatory Bowel Disease and Healthy Older Adults for Whom Immunization Is Recommended. Clin Transl Gastroenterol. 2022 01 19; 13(1):e00446. PMID: 35060934.

    Read at: PubMed
  • Published on 1/5/2022

    Duly K, Farraye FA, Bhat S. COVID-19 vaccine use in immunocompromised patients: A commentary on evidence and recommendations. Am J Health Syst Pharm. 2022 01 05; 79(2):63-71. PMID: 34455440.

    Read at: PubMed
  • Published on 1/1/2022

    Caldera F, Knutson KL, Saha S, Wald A, Phan HS, Chun K, Grimes I, Lutz M, Hayney MS, Farraye FA. Humoral Immunogenicity of mRNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease and Healthy Controls. Am J Gastroenterol. 2022 01 01; 117(1):176-179. PMID: 34797219.

    Read at: PubMed
  • Published on 12/14/2021

    Hadi Y, Dulai PS, Kupec J, Mohy-Ud-Din N, Jairath V, Farraye FA, Kochhar GS. Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease: propensity matched research network analysis. Aliment Pharmacol Ther. 2022 01; 55(2):191-200. PMID: 34904240.

    Read at: PubMed

View 388 more publications: View full profile at BUMC

View all profiles